Michael Daskalakis

24PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedHaematologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 06, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

|Feb 28, 2026
Can hyperleukocytosis be caused by a non-hematologic condition? A 10-year retrospective tertiary-care center cohort study.

Elisavet Moutzouri, Emmanuel Häfliger, Katarzyna Aleksandra Jalowiec

|Aug 28, 2025
Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma.

Corinne Natalie Schmid, Katharina Sponagel, Ulrike Bacher

|Nov 15, 2024
Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial.

Barbara Jeker, Laura Thalmann, Ulrike Bacher

|Jul 27, 2024
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia.

Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel

|May 25, 2024
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation.

Matthias Eggimann, Dilara Akhoundova, Henning Nilius

Pageof 4

Frequent Collaborators

17 joint publications

Thomas Pabst

15 joint publications

Ulrike Bacher

6 joint publications

Katja Seipel

6 joint publications

Dilara Akhoundova